%0 Case Reports
%T Subdural effusion associated with COVID-19 encephalopathy: A case report.
%A Xue ZY
%A Xiao ZL
%A Cheng M
%A Xiang T
%A Wu XL
%A Ai QL
%A Wu YL
%A Yang T
%J World J Clin Cases
%V 12
%N 10
%D 2024 Apr 6
%M 38660075
%F 1.534
%R 10.12998/wjcc.v12.i10.1799
%X <B>BACKGROUND: </B>The precise mechanism by which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacts the central nervous system remains unclear, with manifestations spanning from mild symptoms (e.g., olfactory and gustatory deficits, hallucinations, and headache) to severe complications (e.g., stroke, seizures, encephalitis, and neurally demyelinating lesions). The occurrence of single-pass subdural effusion, as described below, is extremely rare.<BR><B>METHODS: </B>A 56-year-old male patient presented with left-sided limb weakness and slurred speech as predominant clinical symptoms. Through comprehensive imaging and diagnostic assessments, he was diagnosed with cerebral infarction complicated by hemorrhagic transformation affecting the right frontal, temporal, and parietal regions. In addition, an intracranial infection with SARS-CoV-2 was identified during the rehabilitation process; consequently, an idiopathic subdural effusion developed. Remarkably, the subdural effusion underwent absorption within 6 d, with no recurrence observed during the 3-month follow-up.<BR><B>CONCLUSIONS: </B>Subdural effusion is a potentially rare intracranial complication associated with SARS-CoV-2 infection.